{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:03:33Z","timestamp":1791389013573,"version":"4.3.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04093-w","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T07:07:33Z","timestamp":1746601653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Endophthalmitis following intravitreal injections at a tertiary center: real-life data on incidence, risk factors, management strategies, and visual outcomes"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0596-1452","authenticated-orcid":false,"given":"Sebile","family":"Comcali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2741-1646","authenticated-orcid":false,"given":"Yelda Yildiz","family":"Tasci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8797-9634","authenticated-orcid":false,"given":"Mehmet","family":"Onen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8420-2994","authenticated-orcid":false,"given":"Busra","family":"Gulhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2160-2126","authenticated-orcid":false,"given":"Muzaffer","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8379-4384","authenticated-orcid":false,"given":"Cemal","family":"Cavdarli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2211-3048","authenticated-orcid":false,"given":"Omer Mustafa","family":"Bilgic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0069-2433","authenticated-orcid":false,"given":"Mucella Arikan","family":"Yorgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5769-4021","authenticated-orcid":false,"given":"Yasin","family":"Toklu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7357-5399","authenticated-orcid":false,"given":"Mehmet Numan","family":"Alp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1340-543X","authenticated-orcid":false,"given":"Zeliha","family":"Yazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"4093_CR1","doi-asserted-by":"publisher","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419-31. https:\/\/doi.org\/10.1056\/NEJMoa054481. PMID: 17021318.","DOI":"10.1056\/NEJMoa054481"},{"key":"4093_CR2","doi-asserted-by":"publisher","unstructured":"Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology. 2006;113(3):363\u2013372.e5. https:\/\/doi.org\/10.1016\/j.ophtha.2005.11.019. Epub 2006 Feb 3. PMID: 16458968.","DOI":"10.1016\/j.ophtha.2005.11.019"},{"key":"4093_CR3","doi-asserted-by":"publisher","unstructured":"Campochiaro PA, Hafiz G, Shah SM et al. Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther. 2008;16(4):791-9. https:\/\/doi.org\/10.1038\/mt.2008.10. Epub 2008 Feb 5. PMID: 18362932.","DOI":"10.1038\/mt.2008.10"},{"key":"4093_CR4","doi-asserted-by":"publisher","unstructured":"Rodriguez-Fontal M, Alfaro V, Kerrison JB, Jablon EP. Ranibizumab for diabetic retinopathy. Curr Diabetes Rev. 2009;5(1):47\u201351. https:\/\/doi.org\/10.2174\/157339909787314239. PMID: 19199898.","DOI":"10.2174\/157339909787314239"},{"issue":"8","key":"4093_CR5","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1097\/iae.0b013e31817eda41","volume":"28","author":"RM Silva","year":"2008","unstructured":"Silva RM, Ruiz-Moreno JM, Nascimento J, et al. Short-term efficacy and safety of intravitreal Ranibizumab for myopic choroidal neovascularization. Retina. 2008;28(8):1117\u201323. https:\/\/doi.org\/10.1097\/iae.0b013e31817eda41. PMID: 18788102.","journal-title":"Retina"},{"key":"4093_CR6","doi-asserted-by":"publisher","unstructured":"Lommatzsch A, Spital G, Trieschmann M, Pauleikhoff D. Intraocular application of bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks. Ophthalmologe. 2007;104(4):325-8. German. https:\/\/doi.org\/10.1007\/s00347-006-1456-y. PMID: 17334745.","DOI":"10.1007\/s00347-006-1456-y"},{"issue":"1","key":"4093_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10792-016-0265-9","volume":"37","author":"F Pichi","year":"2017","unstructured":"Pichi F, Nucci P, Baynes K, Lowder CY, Srivastava SK. Sustained-release dexamethasone intravitreal implant in juvenile idiopathic arthritis-related uveitis. Int Ophthalmol. 2017;37(1):221\u20138. https:\/\/doi.org\/10.1007\/s10792-016-0265-9. Epub 2016 May 24. PMID: 27221263.","journal-title":"Int Ophthalmol"},{"issue":"3","key":"4093_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1136\/bjophthalmol-2016-308544","volume":"101","author":"D Bellocq","year":"2017","unstructured":"Bellocq D, Pierre-Kahn V, Matonti F, Burillon C, Voirin N, Dot C, Akesbi J, Milazzo S, Baillif S, Soler V, Wolff B, Scemama C, Malcl\u00e8s A, Weber M, Kodjikian L. Effectiveness and safety of dexamethasone implants for postsurgical macular edema including Irvine-Gass syndrome: the EPISODIC-2 study. Br J Ophthalmol. 2017;101(3):333\u201341. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-308544. Epub 2016 May 17. PMID: 27190126.","journal-title":"Br J Ophthalmol"},{"key":"4093_CR9","doi-asserted-by":"publisher","unstructured":"Kim SJ, Chomsky AS, Sternberg P Jr. Reducing the risk of endophthalmitis after intravitreous injection. JAMA Ophthalmol. 2013;131(5):674-5. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.2914. PMID: 23699844.","DOI":"10.1001\/jamaophthalmol.2013.2914"},{"key":"4093_CR10","doi-asserted-by":"publisher","unstructured":"Jager RD, Aiello LP, Patel SC, Cunningham ET Jr. Risks of intravitreous injection: a comprehensive review. Retina. 2004;24(5):676\u2013\u200998. https:\/\/doi.org\/10.1097\/00006982-200410000-00002. PMID: 15492621.","DOI":"10.1097\/00006982-200410000-00002"},{"key":"4093_CR11","doi-asserted-by":"publisher","unstructured":"Bannerman TL, Rhoden DL, McAllister SK, Miller JM, Wilson LA. The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch Ophthalmol. 1997;115(3):357\u2013\u200961. https:\/\/doi.org\/10.1001\/archopht.1997.01100150359008. PMID: 9076208.","DOI":"10.1001\/archopht.1997.01100150359008"},{"key":"4093_CR12","doi-asserted-by":"publisher","unstructured":"Moss JM, Sanislo SR, Ta CN. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology. 2009;116(8):1498\u2013\u2009501. https:\/\/doi.org\/10.1016\/j.ophtha.2009.02.024. Epub 2009 Jun 5. PMID: 19501409.","DOI":"10.1016\/j.ophtha.2009.02.024"},{"issue":"12","key":"4093_CR13","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1001\/archophthalmol.2011.227","volume":"129","author":"JC Wen","year":"2011","unstructured":"Wen JC, McCannel CA, Mochon AB, Garner OB. Bacterial dispersal associated with speech in the setting of intravitreous injections. Arch Ophthalmol. 2011;129(12):1551\u20134. https:\/\/doi.org\/10.1001\/archophthalmol.2011.227. Epub 2011 Aug 8. PMID: 21825179.","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"4093_CR14","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.ophtha.2011.02.034","volume":"118","author":"CP Shah","year":"2011","unstructured":"Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA, Post-Injection Endophthalmitis (PIE) Study Team. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology. 2011;118(10):2028\u201334. https:\/\/doi.org\/10.1016\/j.ophtha.2011.02.034. Epub 2011 Jun 25. PMID: 21705087.","journal-title":"Ophthalmology"},{"key":"4093_CR15","doi-asserted-by":"publisher","unstructured":"Fintak DR, Shah GK, Blinder KJ et al. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and Ranibizumab. Retina 2008 Nov-Dec;28(10):1395\u20139. https:\/\/doi.org\/10.1097\/IAE.0b013e3181884fd2. PMID: 18827737.","DOI":"10.1097\/IAE.0b013e3181884fd2"},{"key":"4093_CR16","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.2147\/OPTH.S169143","volume":"12","author":"S Kiss","year":"2018","unstructured":"Kiss S, Dugel PU, Khanani AM, et al. Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: A USA claim analysis. Clin Ophthalmol. 2018;12:1625\u201335.","journal-title":"Clin Ophthalmol"},{"key":"4093_CR17","doi-asserted-by":"publisher","unstructured":"Fileta JB, Scott IU, Flynn HW Jr. Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmic Surg Lasers Imaging Retina. 2014 Mar-Apr;45(2):143-9. https:\/\/doi.org\/10.3928\/23258160-20140306-08. PMID: 24635156.","DOI":"10.3928\/23258160-20140306-08"},{"issue":"1","key":"4093_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ajo.2015.04.013","volume":"160","author":"D Dossarps","year":"2015","unstructured":"Dossarps D, Bron AM, Koehrer P, Aho-Gl\u00e9l\u00e9 LS, Creuzot-Garcher C. Endophthalmitis after intravitreal injections: incidence, presentation, management, and visual outcome. Am J Ophthalmol. 2015;160(1):17\u2013e251. Epub 2015 Apr 16. PMID: 25892127.","journal-title":"Am J Ophthalmol"},{"key":"4093_CR19","doi-asserted-by":"publisher","unstructured":"Brynskov T, Kemp H, S\u00f8rensen TL. No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting. Retina. 2014;34(5):951-7. https:\/\/doi.org\/10.1097\/IAE.0000000000000071. PMID: 24317292.","DOI":"10.1097\/IAE.0000000000000071"},{"key":"4093_CR20","doi-asserted-by":"crossref","unstructured":"Torres-Costa S, Ramos D, Brand\u00e3o E et al. Incidence of endophthalmitis after intravitreal injection with and without topical antibiotic prophylaxis. Eur J Ophthalmol. 2021;31(2):600\u2013606. doi: 10.1177\/1120672120902028. Epub 2020 Feb 4. PMID: 32019339.","DOI":"10.1177\/1120672120902028"},{"issue":"1","key":"4093_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ophtha.2013.08.037","volume":"121","author":"P Storey","year":"2014","unstructured":"Storey P, Dollin M, Pitcher J, Reddy S, Vojtko J, Vander J, Hsu J, Garg SJ, Post-Injection Endophthalmitis Study Team. The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection. Ophthalmology. 2014;121(1):283\u20139. Epub 2013 Oct 18. PMID: 24144453.","journal-title":"Ophthalmology"},{"issue":"6","key":"4093_CR22","doi-asserted-by":"publisher","first-page":"e0156431","DOI":"10.1371\/journal.pone.0156431","volume":"11","author":"C Benoist d\u2019Azy","year":"2016","unstructured":"Benoist d\u2019Azy C, Pereira B, Naughton G, Chiambaretta F, Dutheil F. Antibioprophylaxis in prevention of endophthalmitis in intravitreal injection: A systematic review and Meta-Analysis. PLoS ONE. 2016;11(6):e0156431. https:\/\/doi.org\/10.1371\/journal.pone.0156431. PMID: 27257676; PMCID: PMC4892688.","journal-title":"PLoS ONE"},{"key":"4093_CR23","doi-asserted-by":"publisher","unstructured":"Cheung CS, Wong AW, Lui A, Kertes PJ, Devenyi RG, Lam WC. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology. 2012;119(8):1609-14. https:\/\/doi.org\/10.1016\/j.ophtha.2012.02.014. Epub 2012 Apr 4. PMID: 22480743.","DOI":"10.1016\/j.ophtha.2012.02.014"},{"issue":"11","key":"4093_CR24","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1016\/j.ophtha.2015.07.005","volume":"122","author":"BL VanderBeek","year":"2015","unstructured":"VanderBeek BL, Bonaffini SG, Ma L. The association between intravitreal steroids and Post-Injection endophthalmitis rates. Ophthalmology. 2015;122(11):2311\u2013e23151. https:\/\/doi.org\/10.1016\/j.ophtha.2015.07.005. Epub 2015 Aug 15. PMID: 26281823; PMCID: PMC4623879.","journal-title":"Ophthalmology"},{"key":"4093_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ajo.2016.02.028","volume":"165","author":"N Rayess","year":"2016","unstructured":"Rayess N, Rahimy E, Storey P, et al. Postinjection endophthalmitis rates and characteristics following intravitreal bevacizumab, Ranibizumab, and Aflibercept. Am J Ophthalmol. 2016;165:88\u201393. https:\/\/doi.org\/10.1016\/j.ajo.2016.02.028. Epub 2016 Mar 2. PMID: 26944277.","journal-title":"Am J Ophthalmol"},{"key":"4093_CR26","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ajo.2018.11.023","volume":"199","author":"PP Storey","year":"2019","unstructured":"Storey PP, Tauqeer Z, Yonekawa Y, et al. Post-Injection endophthalmitis (PIE) study group. The impact of prefilled syringes on endophthalmitis following intravitreal injection of Ranibizumab. Am J Ophthalmol. 2019;199:200\u20138. Epub 2018 Dec 13. PMID: 30552891.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"4093_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41433-021-01886-3","volume":"37","author":"AY Ong","year":"2023","unstructured":"Ong AY, Rigaudy A, Toufeeq S, Robins J, Shalchi Z, Bindra MS, Charbel Issa P. Intravitreal injections as a leading cause of acute postoperative endophthalmitis-a regional survey in England. Eye (Lond). 2023;37(1):163\u20139. https:\/\/doi.org\/10.1038\/s41433-021-01886-3. Epub 2021 Dec 23. PMID: 34949787; PMCID: PMC9829718.","journal-title":"Eye (Lond)"},{"issue":"6","key":"4093_CR28","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1080\/09273948.2023.2192273","volume":"31","author":"A Markan","year":"2023","unstructured":"Markan A, Dogra M, Katoch D, Tomar M, Mittal H, Singh R. Endogenous endophthalmitis in COVID-19 patients: A case series and literature review. Ocul Immunol Inflamm. 2023;31(6):1191\u20137. Epub 2023 Apr 12. PMID: 37043623.","journal-title":"Ocul Immunol Inflamm"},{"key":"4093_CR29","doi-asserted-by":"publisher","unstructured":"Cruz-I\u00f1igo YJ, Klein K, Reddy RK. Case Report of Abiotrophia Defectiva Endophthalmitis after Repeated Injections of Dexamethasone Intravitreal Implant (OZURDEX). Retin Cases Brief Rep. 2022;16(2):170\u2013173. https:\/\/doi.org\/10.1097\/ICB.0000000000000925. PMID: 31479011.","DOI":"10.1097\/ICB.0000000000000925"},{"key":"4093_CR30","doi-asserted-by":"crossref","unstructured":"London NJ, Chiang A, Haller JA. The Dexamethasone drug delivery system: indications and evidence. Adv Ther. 2011;28(5):351\u2013\u200966. doi: 10.1007\/s12325-011-0019-z. Epub 2011 Mar 12. Erratum in: Adv Ther. 2013;30(6):644. PMID: 21494891.","DOI":"10.1007\/s12325-013-0035-2"},{"issue":"8","key":"4093_CR31","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1007\/s00417-022-05607-8","volume":"260","author":"R Singh","year":"2022","unstructured":"Singh R, Davoudi S, Ness S. Preventive factors, diagnosis, and management of injection-related endophthalmitis: a literature review. Graefes Arch Clin Exp Ophthalmol. 2022;260(8):2399\u2013416. https:\/\/doi.org\/10.1007\/s00417-022-05607-8. Epub 2022 Mar 12. PMID: 35278125; PMCID: PMC8917335.","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04093-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04093-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04093-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T07:07:35Z","timestamp":1746601655000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-04093-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4093"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04093-w","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Ankara Bilkent City Hospital and was conducted in accordance with the declaration of Helsinki. Informed consent was obtained from all participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"278"}}